Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6NOVARTIS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ELTROMBOPAG OLAMINE

US Patent Number : 8062665

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22291

Patent Use Code : U-930

Delist Requested :

Patent Use Description : TREATMENT OF IDIOPATHI...

Patent Expiration Date : 2027-08-01

blank

02

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ELTROMBOPAG OLAMINE

US Patent Number : 8062665

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22291

Patent Use Code : U-1306

Delist Requested :

Patent Use Description : TREATMENT OF THROMBOCY...

Patent Expiration Date : 2027-08-01

blank

03

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ELTROMBOPAG OLAMINE

US Patent Number : 8062665

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22291

Patent Use Code : U-2451

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-01

blank

04

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ELTROMBOPAG OLAMINE

US Patent Number : 8062665

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22291

Patent Use Code : U-1714

Delist Requested :

Patent Use Description : TREATMENT OF THROMBOCY...

Patent Expiration Date : 2027-08-01

blank

05

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ELTROMBOPAG OLAMINE

US Patent Number : 8062665

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22291

Patent Use Code : U-1714

Delist Requested :

Patent Use Description : TREATMENT OF THROMBOCY...

Patent Expiration Date : 2027-08-01

blank

06

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ELTROMBOPAG OLAMINE

US Patent Number : 8062665

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22291

Patent Use Code : U-1714

Delist Requested :

Patent Use Description : TREATMENT OF THROMBOCY...

Patent Expiration Date : 2027-08-01

blank